TrialEuropean urology2022

Health-related Quality of Life of Patients with Locally Advanced or Metastatic Urothelial Cancer Treated with Enfortumab Vedotin after Platinum and PD-1/PD-L1 Inhibitor Therapy: Results from Cohort 1 of the Phase 2 EV-201 Clinical Trial.

Bradley McGregor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.